Affiliation:
1. Department of Chemistry, Guru Jambheshwar University of Science and Technology, Hisar-125001, Haryana, India
2. Department of Chemistry, Government College, Hisar-125001, Haryana, India
Abstract
Abstract:
The aim of this review is to collate literature work reported by researchers (from 1994 to 2021) to provide an overview of the available methodologies for the synthesis and diverse pharmacological activities exhibited by pyrazole based molecules. This review highlights recent reports on various routes of synthesis and potential biological evaluation studies viz. anticancer, AT (II) inhibitory, anti-inflammatory activities, HIV-1-RT inhibitory, antihypertensive, herbicidal, antitubercular, insecticidal, antiviral, antimicrobial and COX-2 inhibitory activity, etc. of pyrazole derivatives and also presents recent efforts made on this heterocyclic moiety.
Funder
University Grants Commission, India
Council of Scientific & Industrial Research, New Delhi
Publisher
Bentham Science Publishers Ltd.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Molecular Investigations of Novel Pyrano[2,3-c]Pyrazole Congeners as Potential HCoV-229E Inhibitors: synthesis, Molecular Modeling, 3D QSAR, and ADMET Screening;Polycyclic Aromatic Compounds;2024-09-11
2. Facile synthesis and
in silico
studies of benzothiazole-linked hydroxypyrazolones targeting
α
-amylase and
α
-glucosidase;Future Medicinal Chemistry;2024-05-18
3. Synthesis, in silico ADMET prediction analysis, and pharmacological evaluation of sulfonamide derivatives tethered with pyrazole or pyridine as anti-diabetic and anti-Alzheimer's agents;Saudi Pharmaceutical Journal;2024-05
4. Design, synthesis, α-amylase and glucose diffusion inhibition, and molecular docking studies of new indenopyrazolones bearing benzothiazole derivatives;Bioorganic & Medicinal Chemistry Letters;2024-05
5. Discovery of Pyrano[2,3-c]pyrazole Derivatives as Novel Potential Human Coronavirus Inhibitors: Design, Synthesis, In Silico, In Vitro, and ADME Studies;Pharmaceuticals;2024-02-02